Hormonal Birth Control and B6, B12, and Folate Deficiency

Combined hormonal birth control (containing estrogen and a progestin) is used by hundreds of millions of women worldwide and is among the longest and most extensively studied drug classes in medical history — its safety profile for its main indications (pregnancy prevention, cycle regulation, treatment of certain gynecological conditions) is very well understood. Less often discussed, though, is its subtler, metabolic effect on the status of certain micronutrients and vitamins, including several B vitamins that play a key role in one-carbon metabolism — the biochemical pathway underlying DNA synthesis, red blood cell production, and homocysteine regulation.

This isn't a new discovery — the first observations of oral contraceptives' effect on B vitamins date back to the 1970s, shortly after birth control pills entered the market. Since then, the literature on this topic has grown considerably, including several systematic reviews and meta-analyses that largely confirm the same moderate but consistent pattern: lower levels of folate, vitamin B6, and to a lesser extent vitamin B12 in women using combined hormonal contraceptives compared with women not using them.

This article focuses on what the strongest available evidence shows — primarily a meta-analysis on folate and systematic reviews on B6 and B12 — and on why this topic has its greatest practical relevance not during the period of use itself, but at a specific, predictable moment afterward: the decision to plan a pregnancy.

The strongest, most current evidence in this area is a meta-analysis published in the Journal of Obstetrics and Gynaecology Canada, which systematically gathered and summarized the available studies on the relationship between oral contraceptive use and folate levels.

The size of this effect — a drop of about 1.27 µg/L — may seem small taken out of context, but it's worth remembering this is an average change in women who mostly didn't have a prior deficiency. In women with already borderline folate levels (e.g. due to low dietary intake), the same drop could mean crossing from normal into deficient range — which matters clinically above all in the context of pregnancy planning, which we return to later.

The evidence for vitamin B6 and B12 is less abundant and somewhat weaker than for folate, but points in a similar direction. A review by Palmery and colleagues, published in the European Review for Medical and Pharmacological Sciences, summarized a broader set of micronutrient deficiencies associated with hormonal birth control use, pointing to folic acid, vitamins B2, B6, B12, vitamin C, vitamin E, and magnesium and selenium as nutrients whose status may be lowered.

A separate review, published in Nutrition Reviews and focused specifically on folate, vitamin B6, and B12, highlights an important distinction: the drop in plasma pyridoxal-5-phosphate (the active form of vitamin B6) in women using birth control is relatively well and consistently described in the literature, whereas functional indicators of vitamin B12 status (not just plasma concentration) aren't significantly altered in most women studied. This suggests the effect of birth control on B12 may be weaker or less clearly clinically meaningful than the effect on folate and B6.

The mechanism isn't identical for all three vitamins. For folate and vitamin B6, mechanistic hypotheses point to several possible pathways: the estrogen in birth control may affect liver enzymes involved in metabolizing these vitamins, increase their metabolic turnover, or slightly alter their excretion. For vitamin B6, the effect on enzymes dependent on pyridoxal-5-phosphate involved in tryptophan metabolism is particularly well described — this is partly the origin of the historical hypothesis linking birth control, B6 deficiency, and mood changes, though that last link is far less well confirmed than the drop in vitamin level itself.

For vitamin B12, the mechanism is less clear and, as noted above, the effect is weaker — some studies suggest a modest effect on serum B12-binding proteins, which could lower measured total B12 without a proportional effect on its biologically active fraction or actual tissue status. This differs from the much better-understood, calcium-dependent impairment of B12 absorption seen with metformin, which we cover separately in our article on metformin and vitamin B12.

Regardless of the exact mechanism, the common thread for all three vitamins is their role in the same one-carbon metabolism pathway — folate, B6, and B12 work together in converting homocysteine back into methionine and in synthesizing the nucleotides needed for cell division. Lowering the status of more than one of these vitamins at once (which has been observed in some women on birth control) may have a greater combined effect on this pathway than lowering just one of them.

The practical relevance of this topic doesn't lie primarily in the period of birth control use itself — in most healthy women without additional risk factors, the moderate drop in folate or B6 described in studies doesn't cause clear clinical symptoms. The key moment is the period right after stopping birth control to try to conceive, when adequate folate status is especially important — folate is essential for proper closure of the fetal neural tube, which happens very early, often before pregnancy is even confirmed.

Standard public health recommendations — including those from the CDC and many national gynecological societies — recommend folic acid supplementation (usually 400 mcg daily) for all women of reproductive age planning a pregnancy, regardless of prior birth control use. This recommendation doesn't stem solely from the effect of birth control, but the lower folate levels documented in some women using hormonal contraceptives are an additional, concrete argument for not delaying supplementation until after a pregnancy is confirmed with a test, but starting from the moment the decision to plan one is made.

This distinction — between a statistically significant population-level effect and a clinically meaningful deficiency in a specific person — is key to interpreting this kind of study in practice, not only in the context of birth control, but across most topics covered in this series of articles on drug-micronutrient interactions.

This topic differs from many other drug-micronutrient interactions covered in this series, because its greatest practical relevance isn't during the period of drug use itself, but at a specific, predictable moment afterward — the decision to plan a pregnancy. That means the simplest, most effective intervention isn't a routine "just in case" blood test during years of birth control use, but a simple shift in the timing of folic acid supplementation — starting it before, not after, stopping the pill.